Critical Comparison: NeueHealth (NEUE) & Its Rivals

NeueHealth (NYSE:NEUE) is one of 14 public companies in the “Hospital & medical service plans” industry, but how does it weigh in compared to its competitors? We will compare NeueHealth to similar businesses based on the strength of its earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Institutional & Insider Ownership

63.9% of NeueHealth shares are held by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are held by institutional investors. 64.3% of NeueHealth shares are held by company insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	0.04%	-1.59%	-0.04%

Risk and Volatility

NeueHealth has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 0.95, indicating that their average share price is 5% less volatile than the S&P 500.

Valuation and Earnings

This table compares NeueHealth and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$80.60 billion	$2.78 billion	8.68

NeueHealth’s competitors have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for NeueHealth and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	94	1116	2552	98	2.69

NeueHealth currently has a consensus target price of $8.00, indicating a potential upside of 35.36%. As a group, “Hospital & medical service plans” companies have a potential upside of 18.89%. Given NeueHealth’s higher possible upside, equities research analysts clearly believe NeueHealth is more favorable than its competitors.

Summary

NeueHealth competitors beat NeueHealth on 10 of the 13 factors compared.

NeueHealth Company Profile

NeueHealth, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.